117 related articles for article (PubMed ID: 3385734)
1. Dopamine receptor modulation by conformationally constrained analogues of Pro-Leu-Gly-NH2.
Yu KL; Rajakumar G; Srivastava LK; Mishra RK; Johnson RL
J Med Chem; 1988 Jul; 31(7):1430-6. PubMed ID: 3385734
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and dopamine receptor modulating activity of lactam conformationally constrained analogues of Pro-Leu-Gly-NH2.
Sreenivasan U; Mishra RK; Johnson RL
J Med Chem; 1993 Jan; 36(2):256-63. PubMed ID: 8093736
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
Johnson RL; Rajakumar G; Yu KL; Mishra RK
J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position.
Johnson RL; Rajakumar G; Mishra RK
J Med Chem; 1986 Oct; 29(10):2100-4. PubMed ID: 2876103
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of analogues of Pro-Leu-Gly-NH2 modified at the leucyl residue.
Johnson RL; Bontems RJ; Yang KE; Mishra RK
J Med Chem; 1990 Jun; 33(6):1828-32. PubMed ID: 1971310
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor modulation by a highly rigid spiro bicyclic peptidomimetic of Pro-Leu-Gly-NH2.
Genin MJ; Mishra RK; Johnson RL
J Med Chem; 1993 Oct; 36(22):3481-3. PubMed ID: 7901418
[TBL] [Abstract][Full Text] [Related]
7. Modulation of high-affinity CNS dopamine D2 receptor by L-pro-L-leu-glycinamide (PLG) analogue 3(R)-(N-L-prolylamino)-2-oxo-1-pyrrolidineacetamide.
Mishra RK; Srivastava LK; Johnson RL
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):821-7. PubMed ID: 1981396
[TBL] [Abstract][Full Text] [Related]
8. Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2.
Subasinghe NL; Bontems RJ; McIntee E; Mishra RK; Johnson RL
J Med Chem; 1993 Aug; 36(16):2356-61. PubMed ID: 8103113
[TBL] [Abstract][Full Text] [Related]
9. Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide.
Dolbeare K; Pontoriero GF; Gupta SK; Mishra RK; Johnson RL
Bioorg Med Chem; 2003 Sep; 11(18):4103-12. PubMed ID: 12927872
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
Dolbeare K; Pontoriero GF; Gupta SK; Mishra RK; Johnson RL
J Med Chem; 2003 Feb; 46(5):727-33. PubMed ID: 12593653
[TBL] [Abstract][Full Text] [Related]
11. Conformation and activity of +H2-Pro-Leu-Gly-NH2 and its analogues modified at the leucyl residue.
Kim YJ; Han SJ; Kim SC; Kang YK
Int J Pept Protein Res; 1995 Nov; 46(5):381-90. PubMed ID: 8567182
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
[TBL] [Abstract][Full Text] [Related]
13. Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor.
Mann A; Verma V; Basu D; Skoblenick KJ; Beyaert MG; Fisher A; Thomas N; Johnson RL; Mishra RK
Eur J Pharmacol; 2010 Sep; 641(2-3):96-101. PubMed ID: 20639138
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
[TBL] [Abstract][Full Text] [Related]
15. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
Clement-Cormier Y; Abel M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
[TBL] [Abstract][Full Text] [Related]
16. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
17. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
Verma V; Mann A; Costain W; Pontoriero G; Castellano JM; Skoblenick K; Gupta SK; Pristupa Z; Niznik HB; Johnson RL; Nair VD; Mishra RK
J Pharmacol Exp Ther; 2005 Dec; 315(3):1228-36. PubMed ID: 16126839
[TBL] [Abstract][Full Text] [Related]
18. Enantiopure 4- and 5-aminopiperidin-2-ones: regiocontrolled synthesis and conformational characterization as bioactive beta-turn mimetics.
Weber K; Ohnmacht U; Gmeiner P
J Org Chem; 2000 Nov; 65(22):7406-16. PubMed ID: 11076597
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of the dopamine D2 receptor by Pro-Leu-Gly-NH2 peptidomimetics constrained in either a polyproline II helix or a type II beta-turn conformation.
Raghavan B; Skoblenick KJ; Bhagwanth S; Argintaru N; Mishra RK; Johnson RL
J Med Chem; 2009 Apr; 52(7):2043-51. PubMed ID: 19271750
[TBL] [Abstract][Full Text] [Related]
20. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
